Patients, payers, and paradigm shifts: what to do about Helicobacter pylori.
Graham
D Y
DY
Rabeneck
L
L
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001706:Biopsy; D001944:Breath Tests; D004396:Coloring Agents; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D004381:Duodenal Ulcer / Q000175:diagnosis / Q000209:etiology*; D004415:Dyspepsia / Q000175:diagnosis / Q000209:etiology; D004724:Endoscopy; D016481:Helicobacter Infections / Q000175:diagnosis* / Q000188:drug therapy; D016480:Helicobacter pylori / Q000302:isolation & purification; D006801:Humans; D013276:Stomach Ulcer / Q000175:diagnosis / Q000209:etiology*
D000900:Anti-Bacterial Agents; D004396:Coloring Agents